My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Iterum Therapeutics plc - Ordinary Share (NQ:ITRM)

0.3490 -0.0100 (-2.79%)

Streaming Delayed Price Updated: 12:37 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iterum Therapeutics plc - Ordinary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >

Wondering what's happening in today's after-hours session? ↗

December 31, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 18, 2025

Via Benzinga

Iterum Therapeutics (ITRM) Earnings Transcript ↗

November 14, 2025

Iterum Therapeutics (ITRM) Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

Iterum Therapeutics PLC (NASDAQ:ITRM) Stock Plummets on Wider-Than-Expected Q3 Loss ↗

November 14, 2025

Iterum Therapeutics stock plunges after Q3 2025 earnings miss estimates, with a wider-than-expected loss overshadowing its new product launch.

Via Chartmill

Topics Earnings

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Insights Ahead: Iterum Therapeutics's Quarterly Earnings ↗

August 04, 2025

Via Benzinga

A Look Ahead: Iterum Therapeutics's Earnings Forecast ↗

May 12, 2025

Via Benzinga

A Look at Iterum Therapeutics's Upcoming Earnings Report ↗

November 13, 2024

Via Benzinga

Earnings Scheduled For November 14, 2025 ↗

November 14, 2025

Via Benzinga

A Glimpse of Iterum Therapeutics's Earnings Potential ↗

November 13, 2025

Via Benzinga

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More ↗

November 10, 2025

Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, Plug and Circle.

Via Benzinga

ITRM Reports Results ↗

August 05, 2025

Via The Motley Fool

Topics Intellectual Property

Iterum Therapeutics PLC (NASDAQ:ITRM) Reports Wider Q2 2025 Loss, Market Optimistic Ahead of ORLYNVAH Launch ↗

August 05, 2025

Iterum Therapeutics PLC reports Q2 2025 earnings with a wider loss than expected, but stock rises 4.15% pre-market as investors anticipate ORLYNVAH's August 2025 launch. Cash reserves extend into...

Via Chartmill

Which stocks are moving after the closing bell on Monday? ↗

August 04, 2025

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 23, 2025

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Top movers in Tuesday's pre-market session ↗

April 29, 2025

The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 29, 2025

Via Benzinga

Earnings Scheduled For February 7, 2025 ↗

February 07, 2025

Via Benzinga

Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday? ↗

February 07, 2025

Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite.

Via Benzinga

Topics Economy World Trade

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 10, 2024

Via Benzinga

Earnings Scheduled For November 14, 2024 ↗

November 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 28, 2024

Via Benzinga

FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships ↗

October 28, 2024

Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first approved indication and a U.S. first for oral penems.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 25, 2024

Via Benzinga

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024 ↗

August 14, 2024

ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024 ↗

May 13, 2024

ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 01, 2024

It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023 ↗

March 28, 2024

ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Earnings Scheduled For March 28, 2024 ↗

March 28, 2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.